Because of the roles of FGF19 signaling in lipid metabolism and carcinogenesis, it is truly important to understand the mechanism(s) regarding the pathogenesis of NASH contributing to carcinogenetic progression. The gene discussed is FGF19; the disease is metabolic dysfunction-associated steatohepatitis.